A rare disease is defined by the European Union as one that affects less than 5 in 10,000 of the general population.1
To date, between 6000 and 8000 rare diseases have been discovered and new diseases are regularly described in medical literature. Approximately 80% of rare diseases are of genetic origin. Despite being described as ‘rare’, collectively rare diseases affect the lives of around 3 million people in the UK.2
Only 5% of rare diseases have a licensed treatment3
Chiesi are committed to finding breakthrough solutions to meet the unmet needs and improve the lives of patients with Rare Diseases.
Chiesi are industry pioneers in regenerative medicine, with the first-ever stem-cell-based therapy approved in the EU4 and the first to receive a positive NICE recommendation in England5
The UK Rare Disease team will strive to work with patient organisations, clinicians and the wider healthcare system to help create a brighter future for patients with Rare Diseases.
References
UK-CHI-1900426 December 2019
